A Comparative Analysis of the Utility of Nottingham Prognostic Index and Ki-67 in Selecting ER-positive HER2-negative Patients for Oncotype DX Testing

Clinical Breast Cancer 2026

View at publisher

Authors: Anita Golash, Chandeena Roshanlall, Jalal Kokan, Vanessa Clay, Maryam Khan, Caroline Wilson

DOI: 10.1016/j.clbc.2026.02.008

Cited by: 0

References: 21

Fields of Study & Subjects

Breast Cancer Treatment Studies BRCA gene mutations in cancer Breast Lesions and Carcinomas

References 21